HEALTHMay 29 · 21:32 UTCSTAT NEWSAdam Feuerstein, Matthew Herper, and Angus Chen

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

The article highlights positive data presented at the ASCO annual meeting for Bristol in multiple myeloma and Pfizer in lung cancer. STAT's coverage focuses on key developments from the event, emphasizing advancements in cancer treatments.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

BristolorganizationPfizerorganizationmultiple myelomatopiclung cancertopicASCOorganizationSTATorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHApr 16 · 16:19 UTC
A Deadly Cancer Is Seeing Real Progress
HEALTHMay 27 · 00:00 UTC
Five highlights from lung-cancer research
HEALTHMay 27 · 00:00 UTC
Science takes on the world’s most lethal malignancy
HEALTHApr 15 · 00:00 UTC
Here are the top locations for cancer research in the Nature Index
HEALTHMay 27 · 00:00 UTC
Lung cancer in women emerges as a distinct disease
HEALTHMay 27 · 00:00 UTC
Drugs that boost immunity are making lung cancer less deadly